Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa
Clinical trial NCT05938075 · COMPLETED
Trial details
- NCT number
- NCT05938075
- Sponsor
- Vaccine Company, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-04
- Primary completion
- 2024-07-25
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.